Form 4 for INDP Indaptus Therapeutics, Inc.
Accepted 2024-11-26 00:00:00 ET · period of report 2024-11-25 · accession 0001493152-24-047808 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-26 | 2024-11-25 | INDP | Meckler Jeffrey A | CEO, Dir | A - Grant | $1.18 | +42.6K | 202.9K | +27% | +$50.2K |
| D | 2024-11-26 | 2024-11-25 | INDP | Meckler Jeffrey A | CEO, Dir | A - Grant | $1.18 | +42.6K | 42.6K | New | +$50.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-11-25 | A | A | 42,553 | $1.18 | 202,859 | D | — | — | (F1) The Reporting Person acquired 42,553 shares of common stock and 42,553 warrants to purchase common stock from the Issuer for an aggregate purchase price of $49,999.78. |
| 2 | Derivative | Common Stock Warrants | 2024-11-25 | A | A | 42,553 | $1.18 | 42,553 | D | $1.05 · — to 2029-11-25 | 42,553 Common Stock | (F1) The Reporting Person acquired 42,553 shares of common stock and 42,553 warrants to purchase common stock from the Issuer for an aggregate purchase price of $49,999.78. |